These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4055050

  • 1. Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
    Lode H, Glatzel PD.
    Infection; 1985; 13 Suppl 1():S25-7. PubMed ID: 4055050
    [Abstract] [Full Text] [Related]

  • 2. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM, Veldkamp J, Deleers L.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [Abstract] [Full Text] [Related]

  • 3. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N, van Laethem Y, Vanhoof R, George C, Rapin M, Butzler JP.
    Scand J Infect Dis; 1982 Dec; 14(1):57-60. PubMed ID: 6280269
    [Abstract] [Full Text] [Related]

  • 4. An overview of cefotaxime therapy in infections caused by gram-positive pathogens.
    Iannini PB.
    Infection; 1985 Dec; 13 Suppl 1():S3-6. PubMed ID: 4055052
    [Abstract] [Full Text] [Related]

  • 5. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L, Minns P, Hageage G.
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [Abstract] [Full Text] [Related]

  • 6. Clinical experience of cefotaxime in infections caused by gram-positive pathogens.
    Bassetti D, Solbiati M, Fraizzoli G.
    Infection; 1985 Apr; 13 Suppl 1():S112-4. PubMed ID: 4055040
    [Abstract] [Full Text] [Related]

  • 7. A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.
    Karakusis PH, Trenholme GM, Levin S.
    Infection; 1985 Apr; 13 Suppl 1():S46-9. PubMed ID: 4055055
    [Abstract] [Full Text] [Related]

  • 8. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P, Zamith M, Videira W, Cardosa T, Marques RA, Avila R.
    Chemotherapy; 1989 Apr; 35 Suppl 2():33-40. PubMed ID: 2612238
    [Abstract] [Full Text] [Related]

  • 9. A comparison of cefotaxime and cefoperazone in respiratory tract infections.
    Garcia-Rodriguez JA, Gomez-Garcia AC.
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():301-6. PubMed ID: 6094456
    [Abstract] [Full Text] [Related]

  • 10. Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.
    Gomis M, Herranz A, Aparicio P, Filloy JL, Pastor J.
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():45-52. PubMed ID: 2228844
    [Abstract] [Full Text] [Related]

  • 11. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
    [Abstract] [Full Text] [Related]

  • 12. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
    Kaneko H, Masaki T, Yamaguchi R, Takahashi N, Umeda M, Shirai T.
    Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
    [Abstract] [Full Text] [Related]

  • 13. Experience with cefotaxime in infections caused by gram-positive pathogens, especially Staphylococcus aureus.
    Fujii R.
    Infection; 1985 Sep; 13 Suppl 1():S9-13. PubMed ID: 4055062
    [Abstract] [Full Text] [Related]

  • 14. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L, Minns P, Hageage G.
    Adv Ther; 1995 Sep; 12(1):62-71. PubMed ID: 10150322
    [Abstract] [Full Text] [Related]

  • 15. Cefotaxime (HR-756) in urinary tract infections.
    Paradisi F, Cristiano P, Mirone V, D'Armiento V, Iovene MR.
    Chemotherapy; 1982 Sep; 28(1):64-9. PubMed ID: 6276110
    [Abstract] [Full Text] [Related]

  • 16. Clinical experience with cefotaxime in internal medicine between 1981 and 1984.
    Shah PM, Wiesel M, Stille W.
    Drugs; 1988 Sep; 35 Suppl 2():190-4. PubMed ID: 3135168
    [No Abstract] [Full Text] [Related]

  • 17. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ, Dworzack DL, Preheim LC, Tofte RW, Crossley KB.
    Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
    [Abstract] [Full Text] [Related]

  • 18. Cefotaxime for the treatment of gram-positive urinary tract infection.
    Piccinno A, Pagliarulo A.
    Infection; 1985 Feb; 13 Suppl 1():S100-2. PubMed ID: 4055038
    [Abstract] [Full Text] [Related]

  • 19. [Treatment results using cefixime for bacterial respiratory tract infections].
    Leonhardt L.
    Infection; 1990 Feb; 18 Suppl 3():S115-8. PubMed ID: 2079368
    [Abstract] [Full Text] [Related]

  • 20. The use of cefotaxime in pneumology.
    Grassi C, Colombo ML, Peona V.
    Acta Med Port; 1983 Feb; 4(2):87-90. PubMed ID: 6303060
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.